DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 35 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,311 | -42.4% | 34,617 | -3.6% | 0.00% | – |
| Q2 2023 | $155,062 | +181.0% | 35,894 | -0.5% | 0.00% | – |
| Q1 2023 | $55,175 | -3.2% | 36,062 | 0.0% | 0.00% | – |
| Q4 2022 | $56,982 | +26.6% | 36,062 | -0.5% | 0.00% | – |
| Q3 2022 | $45,000 | -38.4% | 36,248 | 0.0% | 0.00% | – |
| Q2 2022 | $73,000 | -19.8% | 36,248 | -0.5% | 0.00% | – |
| Q1 2022 | $91,000 | -51.1% | 36,412 | -27.0% | 0.00% | – |
| Q4 2021 | $186,000 | -7.0% | 49,884 | 0.0% | 0.00% | – |
| Q3 2021 | $200,000 | +17.6% | 49,884 | +30.3% | 0.00% | – |
| Q2 2021 | $170,000 | -54.2% | 38,284 | -5.6% | 0.00% | – |
| Q1 2021 | $371,000 | -14.7% | 40,576 | -5.4% | 0.00% | – |
| Q4 2020 | $435,000 | +663.2% | 42,905 | +218.5% | 0.00% | – |
| Q3 2020 | $57,000 | -38.7% | 13,472 | 0.0% | 0.00% | – |
| Q2 2020 | $93,000 | – | 13,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,197,245 | $2,993,000 | 1.24% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 265,000 | $663,000 | 0.40% |
| COOPERMAN LEON G | 812,508 | $2,031,270 | 0.11% |
| Ikarian Capital, LLC | 221,252 | $553,000 | 0.07% |
| Shay Capital LLC | 10,000 | $25,000 | 0.00% |
| Sandy Cove Advisors, LLC | 1,200 | $3,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 20,603 | $52,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,269 | $3,000 | 0.00% |
| Patriot Financial Group Insurance Agency, LLC | 1,300 | $3,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 20 | $0 | 0.00% |